Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Century Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −8 vs. Q3 2025
- Shares held
- 25.7M
- +5.43M (+26.8%) vs. Q3 2025
- Total value
- $25.6M
- +$15.5M (+153.0%) vs. Q3 2025
- New holders
- 8
- 9 more added
- Sold out
- 16
- 14 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IPSC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 100 | $387.0M |
| Q1 2026 | 72 | $315.6M |
| Q4 2025 | 47 | $25.6M |
| Q3 2025 | 57 | $10.1M |
| Q2 2025 | 65 | $12.6M |
| Q1 2025 | 70 | $14.1M |
| Q4 2024 | 72 | $36.8M |
| Q3 2024 | 67 | $67.8M |
| Q2 2024 | 61 | $102.3M |
| Q1 2024 | 67 | $96.6M |
| Q4 2023 | 63 | $58.7M |
| Q3 2023 | 55 | $36.1M |
| Q2 2023 | 64 | $61.0M |
| Q1 2023 | 64 | $69.5M |
| Q4 2022 | 65 | $107.2M |
| Q3 2022 | 54 | $208.7M |
| Q2 2022 | 56 | $182.8M |
| Q1 2022 | 52 | $278.9M |
| Q4 2021 | 50 | $335.2M |
| Q3 2021 | 49 | $496.2M |
| Q2 2021 | 36 | $490.8M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Century Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 5,961,631 | $5.93M | 0.01% | +5,961,631 | New |
| DAFNA Capital Management LLC | 2,793,586 | $2.78M | 0.65% | +1,089,354+63.9% | Added |
| Vanguard Group Inc | 2,103,869 | $2.09M | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,838,700 | $1.83M | 0.00% | +1,838,700 | New |
| Two Sigma Investments, LP | 1,495,916 | $1.49M | 0.00% | +584,470+64.1% | Added |
| Spruce Street Capital LP | 1,421,532 | $1.41M | 0.47% | +1,421,532 | New |
| Renaissance Technologies LLC | 1,349,200 | $1.34M | 0.00% | −1,237,700−47.8% | Reduced |
| Two Sigma Advisers, LP | 1,267,700 | $1.26M | 0.00% | +410,100+47.8% | Added |
| Casdin Capital, LLC | 1,228,190 | $1.22M | 0.08% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 1,217,103 | $1.21M | 0.00% | +497,295+69.1% | Added |
| Syncona Portfolio Ltd | 1,213,056 | $1.21M | 3.52% | 00.0% | Unchanged |
| Millennium Management LLC | 610,387 | $607.2K | 0.00% | −133,394−17.9% | Reduced |
| BlackRock, Inc. | 601,866 | $598.7K | 0.00% | +2,210+0.4% | Added |
| Superstring Capital Management LP | 462,963 | $460.6K | 0.25% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 456,115 | $453.9K | 0.00% | +10,806+2.4% | Added |
| Gsa Capital Partners LLP | 333,199 | $331.0K | 0.03% | −270,280−44.8% | Reduced |
| Citadel Advisors LLC | 319,457 | $317.8K | 0.00% | −41,368−11.5% | Reduced |
| UBS Group AG | 214,501 | $213.4K | 0.00% | +214,164+63,550.1% | Added |
| State Street Corp | 127,443 | $126.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 105,052 | $104.5K | 0.00% | +38,052+56.8% | Added |
| Raymond James Financial Inc | 91,323 | $90.8K | 0.00% | 00.0% | Unchanged |
| Algert Global LLC | 76,800 | $76.4K | 0.00% | +76,800 | New |
| FMR LLC | 71,540 | $71.2K | 0.00% | −120,599−62.8% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 77,797 | $70.0K | 0.00% | −56−0.1% | Reduced |
| Prudential Financial Inc | 59,800 | $59.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 50,104 | $49.8K | 0.00% | −17,820−26.2% | Reduced |
| Jane Street Group, LLC | 45,194 | $45.0K | 0.00% | −13,538−23.1% | Reduced |
| HarbourVest Partners LLC | 29,018 | $28.9K | 0.02% | 00.0% | Unchanged |
| Parametrica Management Ltd | 27,840 | $27.7K | 0.04% | 00.0% | Unchanged |
| XTX Topco Ltd | 15,333 | $15.3K | 0.00% | −12,225−44.4% | Reduced |
| Quadrant Private Wealth Management, LLC | 15,286 | $15.2K | 0.00% | 00.0% | Unchanged |
| Scientech Research LLC | 12,355 | $12.3K | 0.01% | +12,355 | New |
| Advisors Asset Management, Inc. | 8,313 | $8.27K | 0.00% | −99−1.2% | Reduced |
| JPMorgan Chase & Co | 3,077 | $3.06K | 0.00% | +1,484+93.2% | Added |
| Simplex Trading, LLC | 2,397 | $2.38K | 0.00% | +2,397 | New |
| SBI Securities Co., Ltd. | 1,530 | $1.52K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,447 | $1.44K | 0.00% | −31−2.1% | Reduced |
| Nisa Investment Advisors, LLC | 883 | $878 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 525 | $522 | 0.00% | −73−12.2% | Reduced |
| Mark Sheptoff Financial Planning, LLC | 500 | $497 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 99 | $98 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 40 | $40 | 0.00% | +40 | New |
| Optiver Holding B.V. | 32 | $32 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $1 | 0.00% | −2,209−100.0% | Reduced |
| Barclays PLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Smartleaf Asset Management LLC | 1 | $1 | 0.00% | +1 | New |
| Royal Bank of Canada | 69 | $0 | 0.00% | −2−2.8% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −3,538,609−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −900,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −236,053−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −60,682−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −54,161−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | −24,018−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,113−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −17,501−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −13,116−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −11,241−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −10,660−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −407−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −118−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −254−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |